US EditionPublished • loading... • Updated
THE POLICY PROGNOSIS | The Inflation Reduction Act Versus 340B: Price Debates, Rebates
Summary by thehoya.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
THE POLICY PROGNOSIS | The Inflation Reduction Act Versus 340B: Price Debates, Rebates
Competing policy efforts to lower drug prices could muddy the waters of drug pricing and leave patients unable to afford their prescription medications. After decades of U.S. citizens paying over double the price for prescription medications compared to other countries part of the Organisation for Economic Co-operation and Development (OECD), the Inflation Reduction Act (IRA) was introduced and… Source
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
